Business Description
Genedrive PLC
ISIN : GB00B1VKB244
Description
Genedrive PLC is a holding company engaged in the molecular diagnostics business. It operates in one operating segment named Diagnostics which is engaged in the Genedrive Point of need molecular diagnostics platform for the diagnosis of infectious diseases and use in patient stratification (genotyping), pathogen detection, and other indications. Geographically the majority of the revenue is derived from the United Kingdom.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 9.5 | |||||
| Equity-to-Asset | 0.44 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -17.91 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 52.2 | |||||
| 3-Year EPS without NRI Growth Rate | 35.9 | |||||
| 3-Year FCF Growth Rate | 27.3 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.63 | |||||
| Quick Ratio | 1.36 | |||||
| Cash Ratio | 0.63 | |||||
| Days Sales Outstanding | 169.08 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -24 | |||||
| Shareholder Yield % | -13.42 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -1802.57 | |||||
| Net Margin % | -1837.5 | |||||
| FCF Margin % | -1415.99 | |||||
| ROE % | -214.17 | |||||
| ROA % | -117.33 | |||||
| ROIC % | -239.95 | |||||
| ROC (Joel Greenblatt) % | -682.82 | |||||
| ROCE % | -238.58 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 8.38 | |||||
| PB Ratio | 1.68 | |||||
| Price-to-Tangible-Book | 1.67 | |||||
| EV-to-EBIT | -1.41 | |||||
| EV-to-EBITDA | -1.48 | |||||
| EV-to-Revenue | 29.42 | |||||
| EV-to-FCF | -2.08 | |||||
| Price-to-Net-Current-Asset-Value | 1.67 | |||||
| Earnings Yield (Greenblatt) % | -70.92 | |||||
| FCF Yield % | -42.34 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:EPSHF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Genedrive PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.344 | ||
| EPS (TTM) ($) | 0 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 0 - 8.47 | ||
| Shares Outstanding (Mil) | 18.69 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Genedrive PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Genedrive PLC Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Genedrive PLC Frequently Asked Questions
What is Genedrive PLC(EPSHF)'s stock price today?
The current price of EPSHF is $8.47. The 52 week high of EPSHF is $8.47 and 52 week low is $0.00.
When is next earnings date of Genedrive PLC(EPSHF)?
The next earnings date of Genedrive PLC(EPSHF) is 2024-11-29 Est..
Does Genedrive PLC(EPSHF) pay dividends? If so, how much?
Genedrive PLC(EPSHF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers